# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-010819
Filing Date
2018-08-13
Accepted
2018-08-13 16:07:58
Documents
84
Period of Report
2018-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0618_immucellcorp.htm | 10-Q | 608039
2 | CERTIFICATION | f10q0618ex31_immucell.htm | EX-31 | 9844
3 | CERTIFICATION | f10q0618ex32_immucell.htm | EX-32 | 5276
| Complete submission text file | 0001213900-18-010819.txt |  | 4826071

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | iccc-20180630.xml | EX-101.INS | 958843
5 | XBRL SCHEMA FILE | iccc-20180630.xsd | EX-101.SCH | 51906
6 | XBRL CALCULATION FILE | iccc-20180630_cal.xml | EX-101.CAL | 56808
7 | XBRL DEFINITION FILE | iccc-20180630_def.xml | EX-101.DEF | 155078
8 | XBRL LABEL FILE | iccc-20180630_lab.xml | EX-101.LAB | 490512
9 | XBRL PRESENTATION FILE | iccc-20180630_pre.xml | EX-101.PRE | 330203

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 181012330
SIC: 2835 In Vitro & In Vivo Diagnostic Substances